Yusen Logistics Benelux Pharmaceutical Import Profile — Belgium (DGFT 2022–2026)

Name: Yusen Logistics Benelux Pharmaceutical Import Records from India — 3 Products, $7.8M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Yusen Logistics Benelux — Pharmaceutical Importer Profile (2026) | 3 Products, $7.8M Trade | TransData Nexus

Yusen Logistics Benelux

Pharmaceutical Importer · Belgium · Gastrointestinal Focus · $7.8M Total Trade · DGFT Verified

Yusen Logistics Benelux is a pharmaceutical importer based in Belgium with a total trade value of $7.8M across 3 products in 2 therapeutic categories. Based on 157 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Yusen Logistics Benelux sources from 2 verified Indian suppliers, with Sun Pharmaceutical Industries Limited accounting for 98.9% of imports.

Yusen Logistics Benelux — Import Portfolio & Supplier Network

Yusen Logistics Benelux import network — 3 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Yusen Logistics Benelux?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Sun Pharmaceutical Industries Limited	$240.0M	9,794	98.9%
Jubilant Generics Limited	$2.6M	206	1.1%

Yusen Logistics Benelux sources from 2 verified Indian suppliers across .

What Formulations Does Yusen Logistics Benelux Import?

Formulation	Value	Ships
Esomeprazole magnesium gastro	$5.3M	157
Pantoprazol Gastro-Resistant tablets 40MG ( pantoprazol basics TAB 40MG ) Each tablet contains: pantoprazole sodium	$1.7M	77
Pantoprazol Gastro-Resistant tablets	$1.7M	42
Levetiracetam tablets 1000MG	$1.6M	46
Gabapentin capsules 300MG ( gabaran CAPS	$1.4M	31
Pantoprazole Gastro-Resistant tablets	$1.3M	44
Simvastatin tablets 20MG ( simva	$1.1M	35
Contiflo xl capsules 0.4MG Pack	$1.1M	23
Ramoclav tablets 875/125MG (amoxiclav	$1.0M	22
Atorvastatin calcium tablets 20MG	$1.0M	48
Atorvastatin calcium tablets 20MG ( atorvastatin sun fc TAB 20MG ) Each Film-Coated tablet contains: atorvastatin calciu	$949.0K	77
Atorvastatin calcium tablets 40MG	$878.7K	35
Memantine hydrochloride tablets 10MG	$876.7K	22
Valsartan tablets 160MG ( valsartan	$875.5K	22
Levetiracetam tablets 500MG	$873.8K	32

Yusen Logistics Benelux imports 5,038 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Esomeprazole	Gastrointestinal	$4.3M	86	0.9%	8
2	Omeprazole	Gastrointestinal	$2.6M	52	0.4%	13
3	Magnesium	Vitamins & Supplements	$950.0K	19	0.3%	6

Yusen Logistics Benelux imports 3 pharmaceutical products across 2 categories into Belgium totaling $7.8M.

Yusen Logistics Benelux — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Yusen Logistics Benelux is a subsidiary of Yusen Logistics, a global logistics provider with over 60 years of expertise in freight forwarding and transportation. Established in 2011, Yusen Logistics Benelux operates across Belgium, the Netherlands, and Luxembourg, offering comprehensive logistics solutions including warehousing, air and ocean freight, contract logistics, and origin cargo management services. The company serves various industries such as automotive, aerospace, retail, healthcare, technology, and food. (craft.co)

Headquartered in Moerdijk, Netherlands, Yusen Logistics Benelux has multiple facilities in Belgium, including locations in Beveren, Herentals, and Machelen. These facilities enable the company to provide efficient logistics services throughout the Benelux region. (craft.co)

2Distribution Network

Yusen Logistics Benelux operates a robust distribution network with multiple facilities across Belgium, the Netherlands, and Luxembourg. In Belgium, the company has warehouses in Beveren, Herentals, and Machelen, strategically located to serve various industries, including pharmaceuticals. The company's logistics capabilities encompass air and ocean freight, contract logistics, and origin cargo management services, ensuring efficient supply chain operations. (craft.co)

3Industry Role

Yusen Logistics Benelux functions primarily as a logistics intermediary within Belgium's pharmaceutical supply chain. While the company imports finished pharmaceutical formulations from India, it does not engage directly in wholesale distribution or parallel importing. Instead, Yusen Logistics Benelux focuses on providing comprehensive logistics solutions, including warehousing, transportation, and supply chain management services, to facilitate the efficient movement of pharmaceutical products within the region. (craft.co)

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Yusen Logistics Benelux

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Yusen Logistics Benelux's sourcing strategy exhibits a high degree of concentration, with 98.9% of its pharmaceutical imports from India supplied by SUN PHARMACEUTICAL INDUSTRIES LIMITED. This single-source dependency may pose risks related to supply chain disruptions, pricing fluctuations, and regulatory changes affecting the supplier. The company's reliance on a single supplier suggests a strategic choice to leverage established relationships and ensure consistent product quality. However, the limited supplier base may impact the stability of the supply chain, especially in the event of unforeseen disruptions.

2Supply Chain Resilience

The resilience of Yusen Logistics Benelux's Indian supply chain is contingent upon the stability and reliability of SUN PHARMACEUTICAL INDUSTRIES LIMITED. The company's exclusive sourcing from this supplier indicates a deep integration and reliance on their operations. The absence of backup suppliers and limited formulation diversity may expose the supply chain to risks associated with production delays, quality issues, or regulatory challenges affecting the primary supplier. Additionally, the company's shipping routes and regulatory compliance are closely tied to SUN PHARMACEUTICAL INDUSTRIES LIMITED's operations, further emphasizing the need for a robust and resilient supply chain strategy.

Importing Pharmaceuticals into Belgium — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Belgium

1Regulatory Authority & Framework

In Belgium, the Federal Agency for Medicines and Health Products (FAMHP) is the primary regulatory authority overseeing pharmaceutical imports. The Royal Decree of 4 September 2022, amending the Royal Decree of 19 April 2001, governs the parallel import of medicines for human use. This legislation outlines the conditions and procedures for obtaining a parallel import license, including requirements for marketing authorization in the exporting European Economic Area (EEA) state.

2Import Licensing & GMP

Import licensing in Belgium requires compliance with FAMHP regulations, including obtaining a parallel import license for medicines. Good Manufacturing Practice (GMP) certificates recognized by the European Union (EU), World Health Organization (WHO), or Pharmaceutical Inspection Co-operation Scheme (PIC/S) are essential for ensuring product quality and safety. Additionally, wholesale distribution authorization is mandatory for entities involved in the distribution of pharmaceutical products within Belgium.

3Quality & Labeling

Yusen Logistics Benelux — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Yusen Logistics Benelux's focus on importing finished pharmaceutical formulations, particularly in the gastrointestinal and vitamins & supplements categories, aligns with market demand for these therapeutic areas. The company's imports of esomeprazole, omeprazole, and magnesium reflect a strategic emphasis on products with established efficacy and a broad patient base. This product strategy caters to the prevalent health concerns in Belgium, such as digestive disorders and nutritional deficiencies, ensuring a steady demand for these imported formulations.

2Sourcing Profile

Yusen Logistics Benelux's sourcing strategy is centered on importing generic pharmaceutical formulations from India, leveraging the country's robust manufacturing capabilities and cost advantages. The company's preference for finished formulations over active pharmaceutical ingredients (APIs) indicates a focus on ready-to-market products that meet regulatory standards. India's established reputation in pharmaceutical manufacturing positions it as a key supplier for Yusen Logistics Benelux's procurement needs.

3Market Positioning

Seller's Guide — How to Become a Supplier to Yusen Logistics Benelux

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to engage with Yusen Logistics Benelux, particularly by offering alternative products or formulations that align with the company's import strategy. Diversifying the supplier base can enhance supply chain resilience and reduce dependency on a single source. Identifying gaps in Yusen Logistics Benelux's current sourcing, such as unmet therapeutic needs or emerging market trends, can provide avenues for new suppliers to introduce innovative products that meet the evolving demands of the Belgian pharmaceutical market.

2Requirements & Qualifications

Indian exporters aiming to supply Yusen Logistics Benelux and the Belgian market must ensure compliance with EU GMP standards and obtain the necessary certifications recognized by FAMHP. Products must meet the quality and safety standards stipulated by Belgian regulations, including batch testing and stability requirements. Additionally, labeling must be in the official languages of Belgium—Dutch, French, and German—and adhere to serialization mandates to facilitate traceability and prevent counterfeit products.

3How to Approach

Frequently Asked Questions — Yusen Logistics Benelux

What products does Yusen Logistics Benelux import from India?

Yusen Logistics Benelux imports 3 pharmaceutical products across 2 categories. Top imports: Esomeprazole ($4.3M), Omeprazole ($2.6M), Magnesium ($950.0K).

Who supplies pharmaceuticals to Yusen Logistics Benelux from India?

Yusen Logistics Benelux sources from 2 verified Indian suppliers. The primary supplier is Sun Pharmaceutical Industries Limited (98.9% of imports, $240.0M).

What is Yusen Logistics Benelux's total pharmaceutical import value?

Yusen Logistics Benelux's total pharmaceutical import value from India is $7.8M, based on 157 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Yusen Logistics Benelux focus on?

Yusen Logistics Benelux imports across 2 categories. The largest: Gastrointestinal (87.9%), Vitamins & Supplements (12.1%).

Get Full Yusen Logistics Benelux Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.